Vir Biotechnology, Inc. - 8-K Filing
Vir Biotechnology announced that Saira Ramasastry stepped down from the Board of Directors effective May 26, 2026 due to a business conflict. Robert More was appointed as Chair of the Audit Committee following her departure. The company also reported results from its annual stockholder meeting held on May 26, where three Class I directors were elected with vote totals ranging between 114.8 million and 115 million votes for each candidate. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $VIR